DE68909416D1 - Radiotherapeutische immunokonjugate, etikettiert mit iod-125. - Google Patents

Radiotherapeutische immunokonjugate, etikettiert mit iod-125.

Info

Publication number
DE68909416D1
DE68909416D1 DE89912700T DE68909416T DE68909416D1 DE 68909416 D1 DE68909416 D1 DE 68909416D1 DE 89912700 T DE89912700 T DE 89912700T DE 68909416 T DE68909416 T DE 68909416T DE 68909416 D1 DE68909416 D1 DE 68909416D1
Authority
DE
Germany
Prior art keywords
iod
radiotherapeutic
immunoconjugates
labeled
radiotherapeutic immunoconjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89912700T
Other languages
English (en)
Other versions
DE68909416T2 (de
Inventor
David Woo
Zenon Steplewski
Jeffrey Mattis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Application granted granted Critical
Publication of DE68909416D1 publication Critical patent/DE68909416D1/de
Publication of DE68909416T2 publication Critical patent/DE68909416T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE89912700T 1988-10-12 1989-10-12 Radiotherapeutische immunokonjugate, etikettiert mit iod-125. Expired - Fee Related DE68909416T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25665588A 1988-10-12 1988-10-12
PCT/US1989/004510 WO1990003799A1 (en) 1988-10-12 1989-10-12 Radiotherapeutic immunoconjugates labeled with iodine-125

Publications (2)

Publication Number Publication Date
DE68909416D1 true DE68909416D1 (de) 1993-10-28
DE68909416T2 DE68909416T2 (de) 1994-03-24

Family

ID=22973055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89912700T Expired - Fee Related DE68909416T2 (de) 1988-10-12 1989-10-12 Radiotherapeutische immunokonjugate, etikettiert mit iod-125.

Country Status (6)

Country Link
US (1) US5130116A (de)
EP (1) EP0440740B1 (de)
JP (1) JPH04501266A (de)
CA (1) CA2000549A1 (de)
DE (1) DE68909416T2 (de)
WO (1) WO1990003799A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019368A (en) * 1989-02-23 1991-05-28 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
EP0364096B1 (de) 1988-09-06 2000-03-08 Xoma Corporation Genexpressions-Elemente und Herstellung von chimären Maus-Mensch-Antikörpern
US20050196400A1 (en) * 1991-05-06 2005-09-08 Xoma Technology Ltd. Production of chimeric mouse-human antibodies with specificity to human tumor antigens
US5463080A (en) * 1992-08-27 1995-10-31 Bracco International B.V. 2,4,6-triiodo-1,3-benzenedicarboxylic acid compounds used as radiolabelling reagents
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
AU2284595A (en) * 1994-04-29 1995-11-29 Center For Molecular Medicine And Immunology Composition for delivery of toxic radioisotopes to the cell nucleus and use
US6348194B1 (en) * 1995-11-13 2002-02-19 Ixsys Incorporated Tumor specific internalizing antigens and methods for targeting therapeutic agents
AU1519699A (en) * 1997-11-07 1999-05-31 Conjuchem, Inc. Affinity markers for human serum albumin
US6998106B1 (en) * 1998-12-01 2006-02-14 Duke University Radioconjugation of internalizing antibodies
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
CN1762990A (zh) * 1999-06-08 2006-04-26 拉卓拉药物公司 包含氨基氧基的化合价平台分子
EP1292337A2 (de) * 2000-06-08 2003-03-19 La Jolla Pharmaceutical Polyethylenoxid mit hohem molekulargewicht enthaltende multivalenz-plattformmoleküle
EP2163256B1 (de) 2001-05-11 2015-09-02 Ludwig Institute for Cancer Research Ltd. Spezifische Bindeproteine und deren Verwendungen
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US20030175818A1 (en) * 2002-03-15 2003-09-18 Ross Amelia A. Devices and methods for isolating and recovering target cells
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
WO2005026325A2 (en) * 2003-09-10 2005-03-24 Surromed, Inc, Bivalent targeting of cell surfaces
US7220730B2 (en) 2003-09-25 2007-05-22 Board Of Regents Of The University Of Nebraska Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
CN101711284A (zh) 2007-01-25 2010-05-19 达娜-法勃肿瘤研究所 抗egfr抗体在治疗egfr突变体介导的疾病中的用途
CN101688229B (zh) 2007-03-15 2013-06-12 路德维格癌症研究所 包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途
CN108424454B (zh) 2007-08-14 2022-05-31 路德维格癌症研究所有限公司 靶向egf受体的单克隆抗体175及其衍生物和用途
CN110570317B (zh) * 2018-08-31 2023-06-20 创新先进技术有限公司 用于车辆核损的方法及装置
CN109453400B (zh) * 2018-10-18 2021-07-13 中国药科大学 一种放射性碘标记金纳米材料及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US4430318A (en) * 1978-11-29 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Immunoassay utilizing 125 I Protein A
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers

Also Published As

Publication number Publication date
WO1990003799A1 (en) 1990-04-19
DE68909416T2 (de) 1994-03-24
CA2000549A1 (en) 1990-04-12
EP0440740B1 (de) 1993-09-22
EP0440740A1 (de) 1991-08-14
JPH04501266A (ja) 1992-03-05
US5130116A (en) 1992-07-14

Similar Documents

Publication Publication Date Title
DE68909416D1 (de) Radiotherapeutische immunokonjugate, etikettiert mit iod-125.
FI896179A0 (fi) Lagerbestaendiga, synnerligen poroesa, kalorifattiga livsmedelsprodukter.
FI893167A0 (fi) Moerk, neutralgrao, nickelfri glaskomposition.
DE58904405D1 (de) 3-aryl-pyrrolidin-2,4-dione.
FI895157A0 (fi) Laosanordning foer flyttbara anordningars, saerskilt sjukvaeddars, hjul.
FI892117A (fi) Enskiktigt, soemmat pappersmaskintyg.
FI892174A0 (fi) Maskinens pressdel foer tillverkning av en fiberbana, speciellt pappersbana.
FI891433A (fi) Behaollare foer transport av loesgods, skaerskilt pulverprodukter.
FI890113A0 (fi) Anvaendning av utvalda aendgruppsslutna fett-alkoholetoxylater foer skumbara, sprutbara rengoeringsmedel.
FI902774A0 (fi) N-imidazolyl- och n -imidazolylmetylderivat av substituerade, bicykliska foereningar.
FI893756A0 (fi) Slaett, keramiskt foerbindningselement.
FI896346A0 (fi) Organiska, svavelhaltiga foereningar foer anvaendning i positiva, elektrostatiska, vaetskeformiga framkallningsmedel.
FI895923A0 (fi) Oralt, mindre missfaergande foerfarande foer foerhindrande av plack.
FI896345A0 (fi) Bipolaert, vaetskeformigt, elektrostatiskt framkallningsmedel.
FI894889A0 (fi) Gripanordning foer gripande av i stroem matade, vikta tryckprodukter.
FI922790A (fi) Koncentrerade vattenhaltiga, vaetskeformiga blekmedelskompositioner.
FI894494A (fi) Foerfarande foer braennsvetsning av hoeguppkolat material, i synnerhet segjaern.
ATE94767T1 (de) Radiotherapeutische immunokonjugate, etikettiert mit iod-125.
FI892163A0 (fi) Valsanordning, saerskilt kalander.
FI896129A0 (fi) Ultraviolettstraolning absorberande kompositioner, vilka innehaoller 1-cyklohexenylacetonitrilderivat av aldehyder.
FI903734A0 (fi) Taendanordning, saerskilt foer en driftsladdning av en rekylfri pansarvaernsvapen.
FI895500A0 (fi) Ledning, inklusive drivanordning foer pappers- eller kartongbanor.
FI892822A (fi) Ljuskaensliga, negativt arbetande offsettryckplattor.
FI890253A0 (fi) Laoda, speciellt foer transport/ uppbevaring av spikpaket.
FI880390A0 (fi) Flaekt, saerskilt en centrifugalflaekt.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee